Salarius Pharmaceuticals Inc. (SLRX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Salarius Pharmaceuticals ...

NASDAQ: SLRX · Real-Time Price · USD
5.68
-0.27 (-4.54%)
At close: Aug 28, 2025, 3:59 PM
5.66
-0.35%
After-hours: Aug 28, 2025, 07:59 PM EDT

Salarius Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.1M -5.57M -5.58M -4.99M -6.46M -8.92M -12.54M -18.03M -30M -30.84M -31.61M -29.34M -18.67M -17.03M -12.77M -10.43M -8.41M -7.12M
Depreciation & Amortization
4.42K 4.42K 4.42K 4.42K 8.93K 9.49K 10.05K 10.62K 6.67K 3.55K 6.68K 9.8K 12.93K 19.18K 19.18K 19.75K 19.18K 18.62K
Stock-Based Compensation
167.74K 229.76K 273.73K 308.06K 360.71K 399K 524.84K 584.97K 610.18K 686.25K 796.8K 797.19K 789.64K 737.57K 559.04K 582.88K 530.91K 416.36K
Other Working Capital
132.55K 505.06K 438.14K 309.95K -154.34K 120.01K -193.35K 409.39K 601.41K 771.59K 1.04M 1.16M 786.95K 474.22K -267.88K -1.13M -1.69M -3.17M
Other Non-Cash Items
103.02K 103.02K 103.02K 676.39K 703.37K 609.29K -1.29M -1.87M 6.87M 6.96M 10.85M 10.81M 1.94M 1.9M -44.69K -23.22K -59.25K 70.57K
Deferred Income Tax
n/a n/a n/a -573.37K -573.37K -479.29K 1.42M 2M 2M 1.9M n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
685.02K 879.72K 669.26K -715.91K -1.72M -2.65M -968.33K 1.26M 2.48M 4.04M 2.36M 2.12M 4.48M 3.37M 2.03M 998.42K -2.1M -2.71M
Operating Cash Flow
-4.14M -4.35M -4.53M -5.29M -7.69M -11.03M -12.85M -16.05M -18.04M -17.24M -17.6M -15.6M -11.44M -11M -10.2M -8.85M -10.02M -9.33M
Capital Expenditures
n/a 4.00 -5 -5 -9 -9 -4 -4 n/a n/a -1.5M -1.5M -1.5M -1.5M n/a -2.6K -2.6K -2.6K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.5M -1.5M -1.5M -1.5M n/a -2.6K -2.6K -2.6K
Debt Repayment
-398.73K -403.35K -466.5K -528.97K -570.56K -453.7K -280.92K -111.47K n/a n/a n/a n/a n/a -191.4K -477.03K -761.1K -949.13K -1.01M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -85.69 -85.69 -85.69 -85.69 n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -487.9K -487.9K -487.9K -487.9K 28.5M 31.74M 31.79M 32.1M
Financial Cash Flow
1.67M 1.78M 1.06M 997.49K -582.22K 6.13M 6.64M 6.81M 6.94M 2.32M 1.99M 2.02M 2.51M 79.5K 28.3M 31.2M 35.88M 36.29M
Net Cash Flow
-2.48M -2.57M -3.47M -4.3M -8.27M -4.9M -6.21M -9.24M -11.11M -14.92M -17.11M -15.08M -10.43M -12.42M 18.1M 22.35M 25.86M 26.97M
Free Cash Flow
-4.14M -4.35M -4.53M -5.29M -7.69M -11.03M -12.85M -16.05M -18.04M -17.24M -19.1M -17.1M -12.94M -12.5M -10.2M -8.86M -10.03M -9.33M